Sign up to save your podcasts
Or
Share 2023 Will Be a Big Year for U.S. Healthcare M&A
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
2023 Will Be a Big Year for U.S. Healthcare M&A
Today we're looking at the biggest trends in U.S. Healthcare M&A as discussed at the recently held J.P. Morgan Healthcare Conference.
“We can expect this to be a big year for M&A for Pharmaceutical and medical device companies,” says our guest Rebecca Wenzel, a senior reporter for Mergermarket. “They are sitting on piles of cash that they’re ready to deploy, though one of the differences we’ll see is that they’re going to be more selective about their roster of assets and assets will be met with more due diligence.”
Listen to learn about:
Dealcast is presented by Mergermarket and SS&C Intralinks.
View all episodes
By SS&C
5
55 ratings
Today we're looking at the biggest trends in U.S. Healthcare M&A as discussed at the recently held J.P. Morgan Healthcare Conference.
“We can expect this to be a big year for M&A for Pharmaceutical and medical device companies,” says our guest Rebecca Wenzel, a senior reporter for Mergermarket. “They are sitting on piles of cash that they’re ready to deploy, though one of the differences we’ll see is that they’re going to be more selective about their roster of assets and assets will be met with more due diligence.”
Listen to learn about:
Dealcast is presented by Mergermarket and SS&C Intralinks.